Industry Portals
Medical Device Industry News
Integer a velit nec risus malesuada imperdiet id et odio. Nunc sit amet mauris dapibus, feugiat diam eget, suscipit, nam gravida nulla eget turpis commodo.
![pexels-cottonbro-3944377](https://www.youngandpartners.com/wp/wp/wp-content/uploads/2021/02/pexels-cottonbro-3944377-scaled.jpg)
M&A Values Hold Strong But Volume Dips (Chemweek March 11-18, 2019)
Young & Partners data shows high total dollars in 2018, but underlying volumes slid
Chemicals M&A at Inflection Point (Y&P article in ICIS March 1-7, 2019 issue)
Transaction trends differ greatly, depending on sector and geography.
CFIUS Reform’s Impact on Biopharma (Phama Exec February 2019 issue)
What the new rules mean for Chinese-related investments and acquisitions in the US
Chemical Week – Young & Partners M&A Interview (Nov 5, 2018 issue)
Young & Partners looks at the chemical M&A market and the role of the mega deals
Good, bad news for Chemical Financing (Y&P article in ICIS Chemical Business) Nov 2 – Nov 8, 2018 issue
Young & Partners’ provides its analysis of what is happening in the stock market and financing worlds.
Business Check – Industry Financial Pulse (Young & Partners article in Pharm Exec Nov 2018)
An in depth look at strategic, M&A and financial trends for Pharma and Biotech
Chemical M&A – Reality vs Myth (Y&P article in ICIS Chemical Business) Oct 26 – Nov 1, 2018 issue
Young & Partners looks at the big picture trends, how they differ from conventional views, and their implications for management.
The Rise of China Biopharma (Pharmaceutical Executive – July issue)
Young & Partners analyzes the rise in China's biopharma industry, both positive and negative
Dr. Spielberg, former Deputy Commissioner of the FDA, joins Young & Partners (June 11, 2018)
Young & Partners adds to its deep regulatory and biopharma expertise
Banker: Value of Closed M&A Soars in 2017 due to Mega Deals (Feb 12 – 19, 2018, Chemical Week)
Peter Young of Young & Partners interviewed about the nuances of the Chemical M&A market in 2017
Stock Market and Financing – Strong with a Twist (ICIS Chemical Business, Feb 2, 2018 issue)
2017 was great for chemical stock market performance and financing, but not for everyone
Pharma and Biotech: Strategic, M&A and Financial Yearend Review and Outlook (Pharma Exec Feb 2018 issue)
Young & Partners reviews what happened in 2017, the future outlook and the implications for management
Chemical M&A – Below the Surface (ICIS Chemical Business, Jan 26, 2018 issue)
Young & Partners looks at the big picture trends and the nuances underneath
Chemical M&A and IPOs – A Warped View – Young & Partners (ICIS Chemical Business Nov. 10 – 16, 2017 issue)
Amid talk of a hot M&A market and IPOs, if you take a hard look at the numbers, reality is different
The Highs, Lows and the Unexpected – Young & Partners (ICIS Chemical Business Sept 8 – 14, 2017 issue)
Young & Partners' observations about chemical industry's stock market performance and financings (debt and equity)